CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
NCT01013415
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infections
Interventions
DRUG:
HAART
BIOLOGICAL:
T cells
Sponsor
University of Pennsylvania